Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heart rate may predict survival and brain function in comatose cardiac arrest survivors

20.10.2014

Researchers may have developed a way to potentially assist prognostication in the first 24 hours after out-of-hospital cardiac arrest (OHCA) when patients are still in a coma. Their findings are revealed today at Acute Cardiovascular Care 2014 by Dr Jakob Hartvig Thomsen from Copenhagen, Denmark.

Acute Cardiovascular Care is the annual meeting of the Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC) and takes place 18-20 October in Geneva, Switzerland.


This figure shows the 180-day mortality rate by experience of sinus bradycardia during therapeutic hypothermia.

Credit: Jakob Hartvig Thomsen

Dr Thomsen said: "When we talk to relatives and friends immediately after a cardiac arrest we often tell them that we're not able to say much about the prognosis for their Dad, Mom, friend, etc, for the next 3 to 4 days. This is incredibly distressing and loved ones are desperate for more information."

He added: "Therapeutic hypothermia is used in comatose survivors of OHCA to protect them from brain damage. Current recommendations say that prognostication should not be made until 72 hours after hypothermia when patients have returned to normothermia and the sedation has worn off.1 The prognostic tools presently available are not reliable until after this 72 hour period."

Dr Thomsen continued: "During hypothermia some patients lower their heart rate, which is called bradycardia. We hypothesised that this is a normal physiological reaction and that these patients may have less severe brain injury after their arrest and therefore lower mortality."

The study was conducted in the intensive care unit at Copenhagen University Hospital during 2004-2010 and was supported by the EU Interreg IV A programme. It included 234 comatose survivors of OHCA who underwent the hospital's standard 24 hour therapeutic hypothermia protocol. Heart rhythm was measured hourly and sinus bradycardia (defined as less than 50 heart beats per minute) was used to stratify the patients. The primary endpoint was 180 day mortality.

The investigators found that patients who experienced sinus bradycardia during therapeutic hypothermia had a 17% 180 day mortality rate compared to 38% in those with no sinus bradycardia (p<0.001) (figure 1), with a hazard ratio (HR) of 0.38. Sinus bradycardia during therapeutic hypothermia remained an independent predictor of lower 180 day mortality with a HR of 0.51 after adjusting for known confounding factors including sex, age, comorbidity, witnessed arrest and bystander CPR.

Dr Thomsen said: "Patients with sinus bradycardia during therapeutic hypothermia had a 50-60% lower mortality rate at 180 days than those with no sinus bradycardia. We also found that sinus bradycardia was directly associated with a better neurological status 180 days after the arrest."

Few patients are in sinus bradycardia when they arrive at the intensive care unit (a period called the induction phase). However the proportion rises during hypothermia to almost 50%, and then declines during the rewarming phase.

Dr Thomsen said: "We speculated that this proportion of patients who develop sinus bradycardia during hypothermia would have better brain function and a lower mortality rate, and that was what we found. "

He added: "Now when we observe that a patient experiences sinus bradycardia below 50 beats per minute within the first 24 hours we can tell families that their relative may have a chance of recovery."

Dr Thomsen continued: "There is a lot of discussion about defining criteria to identify patients we should stop treating when a vegetative state is inevitable. We shouldn't give up on patients who still have a chance so this is an area in which we need to be very certain. Our findings provide an early marker of patients who may do well. Hopefully in the future, together with other tools, we will be able to differentiate between those with a very good or very poor prognosis so we can prioritise intensive care resources."

He concluded: "We are currently validating our findings by conducting the same analysis in the 950 patients included in the Targeted Temperature Management trial which was conducted in 36 intensive care units."

Jacqueline Partarrieu | Eurek Alert!
Further information:
http://www.escardio.org

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>